Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
96
Issue Information66
Letter to the Editor51
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer49
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research38
External validity in distributed data networks36
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”34
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries33
Issue Information32
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–201832
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark31
Issue Information31
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis31
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries25
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review25
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review22
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data22
ORAL PRESENTATION21
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+21
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study20
Data Resource Profile: The Danish National Hospital Medicine Register20
Issue Information20
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems20
0.12914800643921